Cargando…

Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease

We report on the screening and development of haploidentical hematopoietic stem cell transplantation (HSCT) for adult patients with clinically aggressive sickle cell disease (SCD) at our institution. Of 50 adult SCD patients referred for HSCT between January 2014 and March 2017, 20% were denied by i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saraf, Santosh L., Oh, Annie L., Patel, Pritesh R., Sweiss, Karen, Koshy, Matthew, Campbell-Lee, Sally, Gowhari, Michel, Jain, Shivi, Peace, David, Quigley, John G., Khan, Irum, Molokie, Robert E., Mahmud, Nadim, Gordeuk, Victor R., Rondelli, Damiano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Blood and Marrow Transplantation. 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108914/ https://www.ncbi.nlm.nih.gov/pubmed/29656137 http://dx.doi.org/10.1016/j.bbmt.2018.03.031

Ejemplares similares

Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease
por: Saraf, Santosh L., et al.
Publicado: (2020)

Antimicrobial resistance is a risk factor for mortality in adults with sickle cell disease
por: Srisuwananukorn, Andrew, et al.
Publicado: (2020)

Evaluation of point‐of‐care International Normalized Ratio in sickle cell disease
por: Rahman, Syeda, et al.
Publicado: (2021)

Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease
por: Saraf, Santosh L., et al.
Publicado: (2019)

Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation
por: Sweiss, Karen, et al.
Publicado: (2016)

Blockade of TNFα to Improve Human CD34+ Cell Repopulating Activity in Allogeneic Stem Cell Transplantation
por: Senyuk, Vitalyi, et al.
Publicado: (2019)

P-020: IMPLICATIONS OF SOCIOECONOMIC DISTRESS ON NUTRITIONAL STATUS AND KIDNEY FUNCTION IN PEOPLE WITH SICKLE CELL ANEMIA
por: J., HAN, et al.
Publicado: (2022)

Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease
por: Han, Jin, et al.
Publicado: (2021)

Community‐level socioeconomic distress is associated with nutritional status in adults with sickle cell anemia
por: Ally, Syeda Akila, et al.
Publicado: (2023)

COVID-19 Vaccination Status and Disease Burden in Patients with Sickle Cell Disease
por: Han, Jin, et al.
Publicado: (2022)

Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model
por: Mahmud, Nadim, et al.
Publicado: (2018)

Use of multiple urinary biomarkers for the early detection of chronic kidney disease in sickle cell anemia
por: Castro-Sesquen, Yagahira E., et al.
Publicado: (2023)

Conjunctival and pulmonary hemodynamic properties in sickle cell disease subjects with and without pulmonary hypertension
por: Kord Valeshabad, Ali, et al.
Publicado: (2015)

Predictors and clinical complications associated with antiphospholipid antibodies in sickle cell disease
por: Rivera, Claudia Rodriguez, et al.
Publicado: (2023)

Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study
por: Molokie, Robert, et al.
Publicado: (2017)

Improvement of hemolytic anemia with GBT1118 is renoprotective in transgenic sickle mice
por: Ren, Guohui, et al.
Publicado: (2022)

Haptoglobin 1 allele predicts higher serum haptoglobin concentration and lower multiorgan failure risk in sickle cell disease
por: Ruiz, Maria A., et al.
Publicado: (2022)

O-09: DURABLE ENGRAFTMENT AFTER PHARMACOLOGICAL PRE-TRANSPLANT IMMUNOSUPPRESSION FOLLOWED BY REDUCED-TOXICITY MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN HIGHLY HLA-IMMUNIZED ADULTS WITH SICKLE CELL DISEASE
por: S., FÜRST, et al.
Publicado: (2022)

Gene expression changes in sickle cell reticulocytes and their clinical associations
por: Zhang, Xu, et al.
Publicado: (2023)

Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update
por: Patel, Dilan A., et al.
Publicado: (2020)

Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease
por: Chu, Yaya, et al.
Publicado: (2022)

NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation
por: Merli, Pietro, et al.
Publicado: (2022)

Publisher Correction: Gene expression changes in sickle cell reticulocytes and their clinical associations
por: Zhang, Xu, et al.
Publicado: (2023)

Response to NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation
por: Lobo de Figueiredo-Pontes, Lorena, et al.
Publicado: (2022)

Combination treatment of rituximab and donor platelets infusion to reduce donor‐specific anti‐HLA antibodies for stem cells engraftment in haploidentical transplantation
por: Zhang, Rongli, et al.
Publicado: (2020)

PB2439: EARLIER ENGRAFTMENT WITHOUT INCREASE OF GVHD IN HIGHER DOSE OF CD34+ CELLS IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Tan, Tran-Der, et al.
Publicado: (2023)

Social and Demographic Factors Contributing to COVID-19 Vaccine Hesitancy in Patients with Hematologic Malignancies
por: Sweiss, Karen, et al.
Publicado: (2021)

PB2462: IMPACT OF ENGRAFTMENT SYNDROME ON THE DEVELOPMENT OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC/HAPLOIDENTICAL PERIPHERAL BLOOD HSCT IN A SINGLE CENTER IN MEXICO.
por: Daniel Garza Escobar, Juan, et al.
Publicado: (2023)

Comparing the Effectiveness of Education Versus Digital Cognitive Behavioral Therapy for Adults With Sickle Cell Disease: Protocol for the Cognitive Behavioral Therapy and Real-time Pain Management Intervention for Sickle Cell via Mobile Applications (CaRISMA) Study
por: Badawy, Sherif M, et al.
Publicado: (2021)

Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy
por: Kassim, Adetola A., et al.
Publicado: (2022)

P1304: TREATMENT WITH COMBINATION OF RITUXIMAB AND INTRAVENOUS Γ GLOBULIN IS EFFECTIVE IN PROMOTING ENGRAFTMENT IN DONOR SPECIFIC ANTIBODY POSITIVE PATIENTS RECEIVING HAPLOIDENTICAL STEM CELL TRANSPLANT
por: Shen, Yuyan, et al.
Publicado: (2023)

Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy
por: Magnani, Alessandra, et al.
Publicado: (2020)

The Engrafting of Nerves
Publicado: (1845)

AVPR1A and Stress in Adults With Sickle Cell Disease–Related Chronic Pain
por: Roach, Keesha, et al.
Publicado: (2020)

Time to rethink haemoglobin threshold guidelines in sickle cell disease
por: Ballas, Samir K., et al.
Publicado: (2021)

Co-infusion of high-dose haploidentical donor cells and CD19-targeted CART cells achieves complete remission, successful donor engraftment and significant CART amplification in advanced ALL
por: Yu, Changlin, et al.
Publicado: (2020)

Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice
por: Everette, Kelcee A., et al.
Publicado: (2023)

Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease
por: Bhat, Deepali K., et al.
Publicado: (2021)

Sickle Cell Disease Clinical Trials and Phenotypes
por: Ezekekwu, Chinedu A, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v2gd0rslcvpl23b4qmmpf426r7